BIRC5 and chronic myelogenous leukemia, BCR-ABL1 positive: Survivin downregulation resulted in reduced cell viability in imatinib-sensitive CML cells, but not in imatinib-resistant CML cells or Ph chromosome negative cells, showing that survivin is regulated by the BCR-ABL/MAPK cascade in Ph positive CML.